Publications by authors named "Minna Tanner"

Claim this Profile
L
Long-Term Outcomes of Adjuvant Trastuzumab for 9 Weeks or 1 Year for ERBB2-Positive Breast Cancer: A Secondary Analysis of the SOLD Randomized Clinical Trial.
Heikki Joensuu, Judith Fraser, Hans Wildiers, Riikka Huovinen, Päivi Auvinen, Minna Tanner

JAMA Netw Open· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A national precision cancer medicine implementation initiative for Finland.
Katriina J Jalkanen, Erika Alanne, Sanna Iivanainen, Okko-Sakari Kääriäinen, Minna Tanner

Acta Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancer.
Niina Mäenpää, Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, Minna Tanner

BMC Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer.
Karim Fizazi, Alice Bernard-Tessier, Guilhem Roubaud, Tapio Utriainen, Philippe Barthélémy, Minna Tanner

NEJM Evid· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola, Minna Tanner

J Clin Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma.
Antoine Italiano, Philippe A Cassier, Chia-Chi Lin, Tuomo Alanko, Katriina J Peltola, Minna Tanner

Cancer Immunol Immunother· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment.
Outi Huttala, Desiree Loreth, Synnöve Staff, Minna Tanner, Harriet Wikman

Biomedicines· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis.
Johanna Alanko, Minna Tanner, Ritva Vanninen, Anssi Auvinen, Jorma Isola

Breast Cancer Res Treat· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model Informed Dosing Regimen and Phase I Results of the Anti-PD-1 Antibody Budigalimab (ABBV-181).
John Powderly, Alexander Spira, Shunsuke Kondo, Toshihiko Doi, Jason J Luke, Minna Tanner

Clin Transl Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Vascular Network Modified to Function as Culture Platform and Angiogenic Induction Potential Test for Cancer Cells.
Outi Huttala, Synnöve Staff, Tuula Heinonen, Johanna Mäenpää, Minna Tanner

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, Minna Tanner, Outi Lahdenperä

Clin Breast Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High baseline Tie1 level predicts poor survival in metastatic breast cancer.
Leena Tiainen, Emilia A Korhonen, Veli-Matti Leppänen, Tiina Luukkaala, Mari Hämäläinen, Minna Tanner

BMC Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological and prognostic correlations of HER3 expression and its degradation regulators, NEDD4-1 and NRDP1, in primary breast cancer.
Satu Luhtala, Synnöve Staff, Anne Kallioniemi, Minna Tanner, Jorma Isola

BMC Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: The SOLD Randomized Clinical Trial.
Heikki Joensuu, Judith Fraser, Hans Wildiers, Riikka Huovinen, Päivi Auvinen, Minna Tanner

JAMA Oncol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Antibodies for Immunohistochemistry-based Detection of HER3 in Breast Cancer.
Satu Luhtala, Synnöve Staff, Mark Barok, Minna Tanner, Jorma Isola

Appl Immunohistochem Mol Morphol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner

JAMA Oncol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Chorionic Gonadotropin Does Not Correlate with Risk for Maternal Breast Cancer: Results from the Finnish Maternity Cohort.
Renée T Fortner, Helena Schock, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, Minna Tanner

Cancer Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer.
Leena Tiainen, Minna Tanner, Outi Lahdenperä, Pia Vihinen, Arja Jukkola

Anticancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclin E amplification, over-expression, and relapse-free survival in HER-2-positive primary breast cancer.
Satu Luhtala, Synnöve Staff, Minna Tanner, Jorma Isola

Tumour Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does patient education work in breast cancer? Final results from the global CARIATIDE study.
Christos Markopoulos, Patrick Neven, Minna Tanner, Michael Marty, Rolf Kreienberg

Future Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early pregnancy sex steroids and maternal breast cancer: a nested case-control study.
Renée T Fortner, Helena Schock, Rudolf Kaaks, Matti Lehtinen, Eero Pukkala, Minna Tanner

Cancer Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.
Patrick Neven, Christos Markopoulos, Minna Tanner, Michel Marty, Rolf Kreienberg

Breast· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
Heikki Joensuu, Pirkko-Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola-Vuorinen, Minna Tanner

Acta Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bi-weekly paclitaxel and capecitabine as a second- or third-line treatment for advanced breast cancer: a pilot study.
Pirkko-Liiisa Kellokumpu-Lehtinen, Tuija Tuunanen, Anna-Liisa Kautio, Ilari Lehtinen, Minna Tanner

Anticancer Res· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
Fatima Cardoso, Joachim Bischoff, Etienne Brain, Ángel Guerrero Zotano, Hans-Joachim Lück, Minna Tanner

Cancer Treat Rev· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis